Table 1.

Baseline demographic and clinical characteristics of patients with treatment-failure gout (n = 110).

Characteristic
Age, mean (SD) yrs59 (13.2)
Male, n (%)90 (81.8)
Race, n (%)
  White, non-Hispanic75 (68.2)
  Black, non-Hispanic22 (20.0)
  Other13 (11.8)
Duration of disease > 5 yrs, n (%)38 (34.5)
Mean serum uric level, mg/dl (SD)7.81 (2.0)
Mean creatinine level, mg/dl (SD)1.56 (0.8)
Mean rate of gout attacks (flares) per month, past year (SD)0.6 (0.65)
No. of patients with tophi, past year, n (%)77 (70.0)
No. of patients with joint pain, past year, n (%)79 (71.8)
Mean no. of painful joints, past year (SD)8.87 (8.6)
No. of patients with swollen joints, past year, n (%)93 (84.6)
Mean no. of swollen joints, past year (SD)8.6 (8.7)
No. of patients with comorbid conditions, n (%)
  Hypertension78 (71.0)
  Renal disorders, defined by estimated creatinine clearance48 (43.6)
  Osteoarthritis46 (41.8)
  Cardiovascular disorders17 (15.0)
  Diabetes15 (14.0)
  Liver disorders8 (7.3)
  Neoplasms3 (2.7)
  Other conditions43 (3.9)